These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

510 related articles for article (PubMed ID: 30558730)

  • 1. Long-term clinical outcomes and technical factors with the Wallstent for treatment of chronic iliofemoral venous obstruction.
    Gagne PJ; Gagne N; Kucher T; Thompson M; Bentley D
    J Vasc Surg Venous Lymphat Disord; 2019 Jan; 7(1):45-55. PubMed ID: 30558730
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term outcomes following use of a composite Wallstent-Z stent approach to iliofemoral venous stenting.
    Jayaraj A; Noel C; Kuykendall R; Raju S
    J Vasc Surg Venous Lymphat Disord; 2021 Mar; 9(2):393-400.e2. PubMed ID: 32827734
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analysis of threshold stenosis by multiplanar venogram and intravascular ultrasound examination for predicting clinical improvement after iliofemoral vein stenting in the VIDIO trial.
    Gagne PJ; Gasparis A; Black S; Thorpe P; Passman M; Vedantham S; Marston W; Iafrati M
    J Vasc Surg Venous Lymphat Disord; 2018 Jan; 6(1):48-56.e1. PubMed ID: 29033314
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Placement of closed-cell designed venous stents in a mixed cohort of patients with chronic venous outflow obstructions - short-term safety, patency, and clinical outcomes.
    Lichtenberg M; Breuckmann F; Stahlhoff WF; Neglén P; Rick G
    Vasa; 2018 Oct; 47(6):475-481. PubMed ID: 30175948
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of body mass index on initial presentation and outcomes after stenting for quality of life-impairing chronic iliofemoral venous obstruction.
    Jayaraj A; Powell T; Raju S
    J Vasc Surg Venous Lymphat Disord; 2022 Mar; 10(2):325-333.e1. PubMed ID: 34358674
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of native iliac vein aspect ratio on initial clinical presentation and outcomes following stenting for symptomatic chronic iliofemoral venous obstruction.
    Butts H; Jayaraj A
    J Vasc Surg Venous Lymphat Disord; 2024 Sep; 12(5):101900. PubMed ID: 38677552
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Contralateral limb improvement after unilateral iliac vein stenting argues against simultaneous bilateral stenting.
    Jayaraj A; Noel C; Raju S
    J Vasc Surg Venous Lymphat Disord; 2020 Jul; 8(4):565-571. PubMed ID: 32381472
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Utility of the 50% stenosis criterion for patients undergoing stenting for chronic iliofemoral venous obstruction.
    Jayaraj A; Powell T; Raju S
    J Vasc Surg Venous Lymphat Disord; 2021 Nov; 9(6):1408-1415. PubMed ID: 34098125
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anticoagulation reduces iliocaval and iliofemoral stent thrombosis in patients with cancer stented for nonthrombotic venous obstruction.
    Drabkin MJ; Bajwa R; Perez-Johnston R; Bryce Y; Boas FE; Siegelbaum R; Durack JC; Kishore S
    J Vasc Surg Venous Lymphat Disord; 2021 Jan; 9(1):88-94. PubMed ID: 32791307
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Technique of stent sizing in patients with symptomatic chronic iliofemoral venous obstruction-the case for intravascular ultrasound-determined inflow channel luminal area-based stenting and associated long-term outcomes.
    Jayaraj A; Thaggard D; Lucas M
    J Vasc Surg Venous Lymphat Disord; 2023 May; 11(3):634-641. PubMed ID: 36731654
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stent patency in patients with advanced chronic venous disease and nonthrombotic iliac vein lesions.
    Rizvi SA; Ascher E; Hingorani A; Marks N
    J Vasc Surg Venous Lymphat Disord; 2018 Jul; 6(4):457-463. PubMed ID: 29909853
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison between a dedicated venous stent and standard composite Wallstent-Z stent approach to iliofemoral venous stenting: Intermediate-term outcomes.
    Powell T; Raju S; Jayaraj A
    J Vasc Surg Venous Lymphat Disord; 2023 Jan; 11(1):82-90.e2. PubMed ID: 35872144
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pivotal Study of Endovenous Stent Placement for Symptomatic Iliofemoral Venous Obstruction.
    Razavi MK; Black S; Gagne P; Chiacchierini R; Nicolini P; Marston W;
    Circ Cardiovasc Interv; 2019 Dec; 12(12):e008268. PubMed ID: 31833414
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Three-dimensional computed tomography venogram enables accurate diagnosis and treatment of patients presenting with symptomatic chronic iliofemoral venous obstruction.
    Jayaraj A; Raju S
    J Vasc Surg Venous Lymphat Disord; 2021 Jan; 9(1):73-80.e1. PubMed ID: 32800980
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Endovascular recanalization for nonmalignant obstruction of the inferior vena cava.
    Erben Y; Bjarnason H; Oladottir GL; McBane RD; Gloviczki P
    J Vasc Surg Venous Lymphat Disord; 2018 Mar; 6(2):173-182. PubMed ID: 29337042
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intravascular ultrasound evaluation during iliofemoral venous stenting is associated with improved midterm patency outcomes.
    Tran LM; Go C; Zaghloul M; Malak OA; Hager E; Eslami MH; Chaer RA; Avgerinos ED
    J Vasc Surg Venous Lymphat Disord; 2022 Nov; 10(6):1294-1303. PubMed ID: 35872140
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The initial report on 1-year outcomes of the feasibility study of the VENITI VICI VENOUS STENT in symptomatic iliofemoral venous obstruction.
    Razavi M; Marston W; Black S; Bentley D; Neglén P
    J Vasc Surg Venous Lymphat Disord; 2018 Mar; 6(2):192-200. PubMed ID: 29290601
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of degree of stenosis in May-Thurner syndrome on iliac vein stenting.
    Jayaraj A; Buck W; Knight A; Johns B; Raju S
    J Vasc Surg Venous Lymphat Disord; 2019 Mar; 7(2):195-202. PubMed ID: 30553783
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Final 3-Year Study Outcomes from the Evaluation of the Zilver Vena Venous Stent for the Treatment of Symptomatic Iliofemoral Venous Outflow Obstruction (The VIVO Clinical Study).
    Comerota AJ; Gagne P; Brown JA; Segbefia E; Hofmann LV;
    J Vasc Interv Radiol; 2024 Jun; 35(6):834-845. PubMed ID: 38484910
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of venous access site on postintervention stent thrombosis for nonthrombotic iliac vein stenting.
    Chait J; Alsheekh A; Aurshina A; Haggerty J; Ostrozhynskyy Y; Rajaee S; Hingorani A; Ascher E
    J Vasc Surg Venous Lymphat Disord; 2020 Jan; 8(1):84-88. PubMed ID: 31231060
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.